Plain-English translation of NCT06524427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is comparing two different surgical approaches for treating early-stage non-small cell lung cancer: robot-assisted surgery and video-assisted surgery. Both are minimally invasive ways to remove a portion of the lung (called a lobectomy), but the robot-assisted approach uses robotic tools while the video-assisted approach uses cameras and traditional instruments. The study wants to see if the robotic approach works as well as or better than the video-assisted approach in the long term.
Video-assisted surgery has been the standard approach for early-stage lung cancer for many years, but robotic surgery is becoming more common and may have some advantages. This trial exists to rigorously compare both approaches and understand which one gives patients the best outcomes over 5 years.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to receive either robot-assisted or video-assisted lobectomy surgery. Both procedures involve removing the portion of your lung containing the cancer through small incisions. After surgery, you will be followed for at least 5 years with regular check-ups, imaging scans, and blood tests to track how well you're doing and whether the cancer returns. The trial is being conducted at multiple hospitals, so you'll receive care at a participating center near you.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China